Morepen Laboratories Ltd
Company Profile
Business description
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
Contact
Udyog Vihar-III, Sector-20
2nd Floor, Tower C, DLF Cyber Park
GurugramHR122016
INDT: +91 1244892000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
3,125
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
stocks
Undervalued ASX retailer benefiting from rebound in spending
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,874.20 | 25.80 | 0.29% |
| CAC 40 | 8,091.30 | 14.86 | -0.18% |
| DAX 40 | 23,983.83 | 93.04 | -0.39% |
| Dow JONES (US) | 48,061.58 | 52.68 | -0.11% |
| FTSE 100 | 9,788.41 | 103.62 | 1.07% |
| HKSE | 25,468.78 | 233.37 | 0.92% |
| NASDAQ | 22,902.15 | 209.31 | -0.91% |
| Nikkei 225 | 49,512.28 | 128.99 | 0.26% |
| NZX 50 Index | 13,295.91 | 129.04 | -0.96% |
| S&P 500 | 6,761.35 | 38.91 | -0.57% |
| S&P/ASX 200 | 8,585.20 | 21.60 | 0.25% |
| SSE Composite Index | 3,870.28 | 45.47 | 1.19% |